Sorry, this learning module is not available for mobile devices.
COPYRIGHT: Videos of live meetings of PRN in NYC are owned and published by Physicians' Research Network, Inc. Copyright © 2011. All rights reserved.
COLLABORATION STATEMENT: The AIDS Institute is proud of the ongoing collaboration between the Clinical Education Initiative (CEI) and Physicians Research Network (PRN). Founded in 1990, PRN has a well-established reputation for spotlighting the work of the most innovative and influential leaders in the HIV treatment, prevention and research fields through its monthly meetings in New York City. Since 2010, CEI has featured recordings of PRN's monthly events through the CEI website. The combined efforts of both educational institutions have enhanced the continuing educational resources available to New York State clinicians caring for people living with, or at risk for HIV.
Original Release Date: 5/17/2011
Review Date: 5/17/2011
Scott Letendre, MD
Associate Professor of Medicine
University of California, San Diego
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
- Summarize background data on differences between antiretroviral drugs in distribution into the CNS.
- Review the approach to estimating the distribution of antiretroviral regimens into the CNS.
- Review results of studies that have compared estimates of antiretroviral regimens to CNS outcomes, such as HIV RNA levels in cerebrospinal fluid or neurocognitive impairment.
- Suggest an approach to management of clinical patients for prevention and management of HAND.
Scott Letendre, M.D., is an Associate Professor of Medicine in the Department of Medicine, Division of Infectious Diseases, at the University of California, San Diego. Dr. Letendre's research, performed primarily at UCSD's HIV Neurobehavioral Research Center, focuses on the impact on the brain of chronic infections, primarily HIV and HCV, and their treatment. He is also an active investigator in the UCSD unit of the AIDS Clinical Trials Group (ACTG), and is currently a member of both the national ACTG Neurology Subcommittee and the ACTG Dementia Focus Group.
PRN Learning Modules